Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation - Heinze, G; Mitterbauer, C; Regele, H (J Am Soc Nephrol, 2006)